These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1321534)

  • 1. [What is reliable in therapy of liver fibrosis?].
    Högemann B
    Z Gastroenterol; 1992 May; 30(5):333-6. PubMed ID: 1321534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for hepatic fibrosis.
    Brenner DA; Alcorn JM
    Semin Liver Dis; 1990 Feb; 10(1):75-83. PubMed ID: 2186490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor.
    Bickel M; Baringhaus KH; Gerl M; Günzler V; Kanta J; Schmidts L; Stapf M; Tschank G; Weidmann K; Werner U
    Hepatology; 1998 Aug; 28(2):404-11. PubMed ID: 9696004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver fibrosis. 2].
    Hahn EG; Ott U; Martini GA
    Z Gastroenterol; 1980 Oct; 18(10):507-23. PubMed ID: 6109405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.
    Carter EA; McCarron MJ; Alpert E; Isselbacher KJ
    Gastroenterology; 1982 Mar; 82(3):526-34. PubMed ID: 6119272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic collagen synthesis in a rat model of cirrhosis, and its modification by colchicine.
    Tanner MS; Jackson D; Mowat AP
    J Pathol; 1981 Nov; 135(3):179-87. PubMed ID: 6275060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of interferon-alpha on the mRNA expression of procollagen type I and III of hepatic stellate cells and on the deposition of collagen type I and III in fibrotic liver of rats].
    Zhang Q; Wang J; Hu M
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):695-8. PubMed ID: 11715461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine treatment of liver fibrosis.
    Nikolaidis N; Kountouras J; Giouleme O; Tzarou V; Chatzizisi O; Patsiaoura K; Papageorgiou A; Leontsini M; Eugenidis N; Zamboulis C
    Hepatogastroenterology; 2006; 53(68):281-5. PubMed ID: 16608040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolyl hydroxylase activity in liver specimens in chronic liver diseases (author's transl)].
    Langness U; Clausnitzer H; Verspohl M; Grasedyck K
    Med Klin; 1978 Aug; 73(34):1179-82. PubMed ID: 210365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids decrease prolyl hydroxylase activity without the cellular accumulation of underhydroxylated collagen.
    Counts DF; Rojas FJ; Cutroneo KR
    Mol Pharmacol; 1979 Jan; 15(1):99-107. PubMed ID: 218094
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamics of hepatic collagen synthesis and intracellular degradation of newly synthesized collagen during chronic carbon tetrachloride-induced liver injury in rats.
    Koda M; Murawaki Y; Yamamoto H; Kwasaki H
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):233-44. PubMed ID: 8091008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
    Bolarin DM; Andy JJ
    Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].
    Reinhardt M; Jorke D; Jahn G; Krombholz B; Müller A; Machnik G; Kunath H
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):257-75. PubMed ID: 3542496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis.
    Kelley J; Newman RA; Evans JN
    J Lab Clin Med; 1980 Dec; 96(6):954-64. PubMed ID: 6159435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic properties of botanicals in chronic liver disease.
    Stickel F; Brinkhaus B; Krähmer N; Seitz HK; Hahn EG; Schuppan D
    Hepatogastroenterology; 2002; 49(46):1102-8. PubMed ID: 12143213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
    Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
    Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
    Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
    Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.